Roxas C - Search Results

1

Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis.

Kent BD, d'Ancona G, Fernandes M, Green L, Roxas C, Thomson L, Nanzer AM, Kavanagh J, Agarwal S, Jackson DJ. Kent BD, et al. Among authors: roxas c. ERJ Open Res. 2020 Jan 20;6(1):00311-2019. doi: 10.1183/23120541.00311-2019. eCollection 2020 Jan. ERJ Open Res. 2020. PMID: 31984211 Free PMC article.

2

Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma.

d'Ancona G, Kavanagh J, Roxas C, Green L, Fernandes M, Thomson L, Dhariwal J, Nanzer AM, Jackson DJ, Kent BD. d'Ancona G, et al. Among authors: roxas c. Eur Respir J. 2020 May 7;55(5):1902259. doi: 10.1183/13993003.02259-2019. Print 2020 May. Eur Respir J. 2020. PMID: 32060061 Free article.

3

Prevalence and recovery of adrenal insufficiency in steroid-dependent asthma patients receiving biologic therapy.

Nanzer AM, Chowdhury A, Raheem A, Roxas C, Fernandes M, Thomson L, Green L, Dhariwal J, D'Ancona G, Kent BD, Kelly PA, Jackson DJ. Nanzer AM, et al. Among authors: roxas c. Eur Respir J. 2020 Jul 30;56(1):1902273. doi: 10.1183/13993003.02273-2019. Print 2020 Jul. Eur Respir J. 2020. PMID: 32217655 Free article. No abstract available.

4

Real-World Effectiveness and the Characteristics of a "Super-Responder" to Mepolizumab in Severe Eosinophilic Asthma.

Kavanagh JE, d'Ancona G, Elstad M, Green L, Fernandes M, Thomson L, Roxas C, Dhariwal J, Nanzer AM, Kent BD, Jackson DJ. Kavanagh JE, et al. Among authors: roxas c. Chest. 2020 Aug;158(2):491-500. doi: 10.1016/j.chest.2020.03.042. Epub 2020 Apr 8. Chest. 2020. PMID: 32275980

5

Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma.

Kavanagh JE, Hearn AP, Dhariwal J, d'Ancona G, Douiri A, Roxas C, Fernandes M, Green L, Thomson L, Nanzer AM, Kent BD, Jackson DJ. Kavanagh JE, et al. Among authors: roxas c. Chest. 2021 Feb;159(2):496-506. doi: 10.1016/j.chest.2020.08.2083. Epub 2020 Aug 31. Chest. 2021. PMID: 32882249

6

Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis.

Nanzer AM, Dhariwal J, Kavanagh J, Hearn A, Fernandes M, Thomson L, Roxas C, Green L, D'Ancona G, Agarwal S, Kent BD, Jackson DJ. Nanzer AM, et al. Among authors: roxas c. ERJ Open Res. 2020 Nov 10;6(4):00451-2020. doi: 10.1183/23120541.00451-2020. eCollection 2020 Oct. ERJ Open Res. 2020. PMID: 33263051 Free PMC article.

7

Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma.

Kavanagh JE, Hearn AP, d'Ancona G, Dhariwal J, Roxas C, Green L, Thomson L, Fernandes M, Kent BD, Nanzer AM, Jackson DJ. Kavanagh JE, et al. Among authors: roxas c. Allergy. 2021 Jun;76(6):1890-1893. doi: 10.1111/all.14693. Epub 2020 Dec 23. Allergy. 2021. PMID: 33300186 No abstract available.

8

Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma.

d'Ancona G, Kavanagh JE, Dhariwal J, Hearn AP, Roxas C, Fernandes M, Green L, Thomson L, Nanzer AM, Jackson DJ, Kent BD. d'Ancona G, et al. Among authors: roxas c. Allergy. 2021 Jul;76(7):2238-2241. doi: 10.1111/all.14737. Epub 2021 Jan 26. Allergy. 2021. PMID: 33432682 No abstract available.

9

The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma.

Hearn AP, Kavanagh J, d'Ancona G, Roxas C, Green L, Thomson L, Fernandes M, Kent BD, Dhariwal J, Nanzer AM, Jackson DJ. Hearn AP, et al. Among authors: roxas c. J Allergy Clin Immunol Pract. 2021 May;9(5):2093-2096.e1. doi: 10.1016/j.jaip.2021.01.008. Epub 2021 Jan 21. J Allergy Clin Immunol Pract. 2021. PMID: 33486140 No abstract available.

10

Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy.

Hearn AP, Hug OD, Somani ZA, Kavanagh J, d'Ancona G, Roxas C, Green L, Thomson L, Fernandes M, Kent BD, Dhariwal J, Nanzer AM, Jackson DJ. Hearn AP, et al. Among authors: roxas c. Eur Respir J. 2021 Jun 10;57(6):2100166. doi: 10.1183/13993003.00166-2021. Print 2021 Jun. Eur Respir J. 2021. PMID: 33632798 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters